FLT3 Inhibitor Generic AML Med

Gilteritinib is a FLT3 inhibitor. It’s specifically used to treat hard-to-treat acute myeloid leukemia (AML) in people who have those FLT3 mutations. So, it works by shutting down FLT3 kinase, the thing that makes cells grow.

You can get it as 40 mg tablets. Usually, you take them once a day, but the doc might tell you to have 120 mg. It usually comes in a bottle with 90 tabs.

It focuses on the FLT3 receptor in cells, which lots of AML patients with FLT3 mutations have too much of. This makes it a good choice if you’ve tried other treatments and they didn’t work. Just follow the dose exactly to get the most out of it and avoid any unwanted side effects.